BridgeMD
New treatment option for Fibrotic Interstitial Lungs Diseases
Official title Physical Activity and Fibrosing Interstitial Lung Disease
ClinicalTrials.gov ID: NCT06182748
What this study is testing
- What it's testing
- Fibrotic interstitial lungs diseases (ILD) are a group of chronic and rare diseases characterized by an altered blood oxygenation in the lung, leading to dyspnea and physical limitation. Physical training is efficient to fight vicious circle of physical deconditioning observed in ILD.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged ≥ 18 years
- Fibrosing PID with fibrosis score \> 10% of lung volume on chest CT scan
- Be able to attend physical reconditioning 3 times a week
- Be affiliated to a health insurance scheme
- Sign informed consent form
You likely can't join if
- Any contraindication to physical activity (hereafter, after Dany-Michel Marcadeta, Bruno Pavy et al. Recommendations of the French Society of...
- Be unable to perform exercise on an ergocycle or treadmill
- Be unable to perform a stress test, particularly for people on long-term oxygen therapy rest oxygen therapy at home
- IRS during an exacerbation
- Change in treatment \< 3 months
- Sarcoidosis
See the full eligibility criteria
- Patient aged ≥ 18 years
- Fibrosing PID with fibrosis score \> 10% of lung volume on chest CT scan
- Be able to attend physical reconditioning 3 times a week
- Be affiliated to a health insurance scheme
- Sign informed consent form
- Any contraindication to physical activity (hereafter, after Dany-Michel Marcadeta, Bruno Pavy et al. Recommendations of the French Society of Cardiology for stress tests 2018)
- Be unable to perform exercise on an ergocycle or treadmill
- Be unable to perform a stress test, particularly for people on long-term oxygen therapy rest oxygen therapy at home
- IRS during an exacerbation
- Change in treatment \< 3 months
- Sarcoidosis
- Connectivitis
- Pregnancy in progress
- Participation in a therapeutic intervention study
- Patient under guardianship
- Person subject to a legal protection measure
- Patient on state medical aid
The study team makes the final eligibility decision.
Where it's taking place
- Bobigny, Seine Saint Denis, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bobigny, Seine Saint Denis, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.